These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 37137196)

  • 1. Solriamfetol enhances wakefulness and improves cognition and anxiety in a murine model of OSA.
    Badran M; Puech C; Barrow MB; Runion AR; Gozal D
    Sleep Med; 2023 Jul; 107():89-99. PubMed ID: 37137196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recovery Mimicking "Ideal" CPAP Adherence Does Not Improve Wakefulness or Cognition in Chronic Murine Models of OSA: Effect of Wake-Promoting Agents.
    Badran M; Puech C; Barrow MB; Runion AR; Gozal D
    Arch Bronconeumol; 2023 Dec; 59(12):805-812. PubMed ID: 37783638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Solriamfetol improves chronic sleep fragmentation-induced increases in sleep propensity and ameliorates explicit memory in male mice.
    Puech C; Badran M; Barrow MB; Runion AR; Gozal D
    Sleep; 2023 May; 46(5):. PubMed ID: 36866452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Solriamfetol: A Review in Excessive Daytime Sleepiness Associated with Narcolepsy and Obstructive Sleep Apnoea.
    Hoy SM
    CNS Drugs; 2023 Nov; 37(11):1009-1020. PubMed ID: 37847434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative Efficacy and Safety of Wakefulness-Promoting Agents for Excessive Daytime Sleepiness in Patients With Obstructive Sleep Apnea : A Systematic Review and Network Meta-analysis.
    Pitre T; Mah J; Roberts S; Desai K; Gu Y; Ryan C; Busse JW; Zeraatkar D
    Ann Intern Med; 2023 May; 176(5):676-684. PubMed ID: 37155992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized Controlled Trial of Solriamfetol for Excessive Daytime Sleepiness in OSA: An Analysis of Subgroups Adherent or Nonadherent to OSA Treatment.
    Schweitzer PK; Mayer G; Rosenberg R; Malhotra A; Zammit GK; Gotfried M; Chandler P; Baladi M; Strohl KP
    Chest; 2021 Jul; 160(1):307-318. PubMed ID: 33631141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Indirect treatment comparison of solriamfetol, modafinil, and armodafinil for excessive daytime sleepiness in obstructive sleep apnea.
    Ronnebaum S; Bron M; Patel D; Menno D; Bujanover S; Kratochvil D; Lucas E; Stepnowsky C
    J Clin Sleep Med; 2021 Dec; 17(12):2543-2555. PubMed ID: 34402784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Solriamfetol and Modafinil on Arousal and Anxiety-Related Behaviors in Narcoleptic Mice.
    Sakai N; Nishino S
    Neurotherapeutics; 2023 Mar; 20(2):546-563. PubMed ID: 36544071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Explicit memory, anxiety and depressive like behavior in mice exposed to chronic intermittent hypoxia, sleep fragmentation, or both during the daylight period.
    Puech C; Badran M; Runion AR; Barrow MB; Qiao Z; Khalyfa A; Gozal D
    Neurobiol Sleep Circadian Rhythms; 2022 Nov; 13():100084. PubMed ID: 36254342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluating pharmacological treatments for excessive daytime sleepiness in obstructive sleep apnea: A comprehensive network meta-analysis and systematic review.
    Neshat SS; Heidari A; Henriquez-Beltran M; Patel K; Colaco B; Arunthari V; Lee Mateus AY; Cheung J; Labarca G
    Sleep Med Rev; 2024 Aug; 76():101934. PubMed ID: 38754208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Excessive Daytime Sleepiness in Obstructive Sleep Apnea. Mechanisms and Clinical Management.
    Lal C; Weaver TE; Bae CJ; Strohl KP
    Ann Am Thorac Soc; 2021 May; 18(5):757-768. PubMed ID: 33621163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modafinil improves daytime sleepiness in patients with mild to moderate obstructive sleep apnoea not using standard treatments: a randomised placebo-controlled crossover trial.
    Chapman JL; Kempler L; Chang CL; Williams SC; Sivam S; Wong KK; Yee BJ; Grunstein RR; Marshall NS
    Thorax; 2014 Mar; 69(3):274-9. PubMed ID: 24287166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solriamfetol for the Management of Excessive Daytime Sleepiness.
    Cuomo MC; Sheehan AH; Jordan JK
    J Pharm Pract; 2022 Dec; 35(6):963-970. PubMed ID: 33882756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Update on Persistent Excessive Daytime Sleepiness in OSA.
    Javaheri S; Javaheri S
    Chest; 2020 Aug; 158(2):776-786. PubMed ID: 32147246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Solriamfetol Titration & AdministRaTion (START) in Patients With Narcolepsy.
    Thorpy MJ; Hyman D; Parks GS; Chen A; Foley C; Baldys B; Ito D; Singh H
    Clin Ther; 2022 Oct; 44(10):1356-1369. PubMed ID: 36171171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solriamfetol treatment of excessive daytime sleepiness in participants with narcolepsy or obstructive sleep apnea with a history of depression.
    Krystal AD; Benca RM; Rosenberg R; Schweitzer PK; Malhotra A; Babson K; Lee L; Bujanover S; Strohl KP
    J Psychiatr Res; 2022 Nov; 155():202-210. PubMed ID: 36070638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence and duration of common early-onset adverse events in randomized controlled trials of solriamfetol for treatment of excessive daytime sleepiness in obstructive sleep apnea and narcolepsy.
    Rosenberg R; Thorpy MJ; Dauvilliers Y; Schweitzer PK; Zammit G; Gotfried M; Bujanover S; Scheckner B; Malhotra A
    J Clin Sleep Med; 2022 Jan; 18(1):235-244. PubMed ID: 34283019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Profile of Solriamfetol in the Management of Excessive Daytime Sleepiness Associated with Narcolepsy or Obstructive Sleep Apnea: Focus on Patient Selection and Perspectives.
    Abad VC
    Nat Sci Sleep; 2021; 13():75-91. PubMed ID: 33531850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modafinil : a review of its use in excessive sleepiness associated with obstructive sleep apnoea/hypopnoea syndrome and shift work sleep disorder.
    Keating GM; Raffin MJ
    CNS Drugs; 2005; 19(9):785-803. PubMed ID: 16142993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of solriamfetol on on-the-road driving performance in participants with excessive daytime sleepiness associated with obstructive sleep apnoea.
    Vinckenbosch F; Asin J; de Vries N; Vonk PE; Donjacour CEHM; Lammers GJ; Overeem S; Janssen H; Wang G; Chen D; Carter LP; Zhou K; Vermeeren A; Ramaekers JG
    Hum Psychopharmacol; 2022 Nov; 37(6):e2845. PubMed ID: 35633275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.